参考文献/References:
[1] 谢幸 , 苟文丽 . 妇产科学 [M]. 北京 : 人民卫生出版社 , 2019: 64-66. XIE Xing, GOU Wenli. Obstetrics and Gynecology[M]. Beijing: People’s Medical Publishing House, 2019: 64-66.
[2] 张小平 , 余海珍 , 赵家宁 , 等 . 孕妇妊娠中期糖脂代谢紊乱对不良妊娠结局的影响 [J]. 现代检验医学杂志 , 2015, 30(6): 35-38. ZHANG Xiaoping, YU Haizhen , ZHAO Jianing, et al. Impaction of glucose and lipids metabolic abnormalities of pregnant women in second trimester for adverse pregnancy outcomes [J]. Journal of Modern Laboratory Medicine. 2015, 30(6): 35-38.
[3] LIU Jinnan, LI Jing, LI Sainan, et al. Circulating Lysophosphatidylcholines in early pregnancy and risk of gestational diabetes in Chinese women[J]. J Clin Endocrinol Metab, 2020, 105(4): dgaa058.
[4] 樊娜娜 , 詹瑛 , 徐文 , 等 .子痫前期患者血清代谢物水平及其与疾病严重程度的相关性研究 [J].国际检验医学杂志 ,2021,42(5):568-573. FAN Nana, ZHAN Ying, XU Wen. et, al. Study on serum metabolite level and its correlation with disease severity in patients with preeclampsia [J]. International Journal of Laboratory Medicine, 2021,42(5):568-573.
[5] 任丽芬 , 张志平 , 徐蓓 , 等 .孕妇葡萄糖耐量和血清胰岛素及 C-肽释放水平检测对妊娠糖尿病的诊断研究 [J].现代检验医学杂志 , 2020, 35(6):167-170. REN Lifen, ZHANG Zhiping, XU Bei, et al. Study on diagnosis of gestational diabetes mellitus by detection of glucose tolerance,serum insulin and C-peptide release levels in pregnant women [J]. Journal of Modern Laboratory Medicine, 2020, 35(6):167-170.
[6] 吴小绸 , 吴克亮 , 孙晓峰 , 等 .在不同妊娠阶段妊娠期糖尿病孕妇的血清代谢组学的分析 [J].中国临床药理学杂志 , 2019, 35(22):2823-2826. WU Xiaochou, WU Keliang, SUN Xiaofeng. et al. Serum metabolomics analysis of pregnant women with gestational diabetes mellitus in different gestational stages [J]. The Chinese Journal of Clinical Pharmacology, 2019, 35(22): 2823-2826.
[7] LAW S H, CHAN M L, MARATHE G K, et al. An updated review of Lysophosphatidylcholine metabolism in human diseases [J]. Int J Mol Sci, 2019, 20(5):1149.
[8] FURSE S, WHITE S L, MEEK C L, et, al. Altered triglyceride and phospholipid metabolism predates the diagnosis of gestational diabetes in obese pregnancy [J]. Mol Omics. 2019, 15(6):420-430.
[9] LIU Panpan, ZHU Wu, CHEN Chao, et, al. The mechanisms of lysophosphatidylcholine in the development of diseases [J]. Life Sci, 2020, 247: 117443.
[10] YEA K, KIM J, YOON J H, et, al. Lysophosphatidyl-choline activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes [J]. J Biol Chem. 2009, 284(49):33833-40.
[11] DRZAZGA A, OKULUS M, RYCHLICKA M, et al. Lysophosphatidylcholine containing anisic acid is able to stimulate insulin secretion targeting g protein coupled receptors[J]. Nutrients, 2020, 12(4):1173.
[12] DRZAZGA A, KAMI?SKA D, GLISZCZY?SKA A, et al. Isoprenoid derivatives of Lysophosphatidylcholines enhance insulin and GLP-1 secretion through lipid-binding GPCRs[J]. Int J Mol Sci, 2021, 22(11):5748.
[13] TAKAHASHI H, GOTO T, YAMAZAKI Y, et al. Me-tabolomics reveal 1-palmitoyl Lysophosphatidylcholine production by peroxisome proliferator-activated recep-tor α[J]. J Lipid Res, 2015, 56(2):254-265.
[14] WANG Jiayue, WANG Bohong, ZHANG Yan. Agonism activities of Lysophosphatidylcholines (LPC) ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ) [J]. J Biomol Struct Dyn, 2020, 38(2):398-409.
[15] ZHONG Huanzi, FANG Chao, FAN Yanqun, et al.Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals[J].Gigascience, 2017, 6(7):1-12.
相似文献/References:
[1]高 飞,杨红玲,王洁琳,等.妊娠期糖尿病患者红细胞分布宽度与胰岛素抵抗的相关性研究[J].现代检验医学杂志,2017,32(01):66.[doi:10.3969/j.issn.1671-7414.2017.01.018]
GAO Fei,YANG Hong-ling,WANG Jie-lin,et al.Relationship between the Red Cell Volume Distribution Width
in Patients with Gestational Diabetes and Insulin Resistance[J].Journal of Modern Laboratory Medicine,2017,32(06):66.[doi:10.3969/j.issn.1671-7414.2017.01.018]
[2]乔国昱,何亚萍,周 洁.妊娠期糖尿病并发甲状腺功能减退孕妇凝血功能指标的变化研究[J].现代检验医学杂志,2017,32(03):109.[doi:10.3969/j.issn.1671-7414.2017.03.029]
QIAO Guo-yu,HE Ya-ping,ZHOU Jie.Study on the Alteration of Blood Coagulation Function of PregnantWomen with Pothyroidism Companied with Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(06):109.[doi:10.3969/j.issn.1671-7414.2017.03.029]
[3]肖鸽飞,李 桦,孟小军,等.孕妇FTO基因的表达与胰岛素水平相关性的研究[J].现代检验医学杂志,2017,32(05):44.[doi:10.3969/j.issn.1671-7414.2017.05.012]
XIAO Ge-fei,LI Hua,MENG Xiao-jun,et al.Correlation Study on FTO Expression
and Insulin Secretion Level in Pregnant Women[J].Journal of Modern Laboratory Medicine,2017,32(06):44.[doi:10.3969/j.issn.1671-7414.2017.05.012]
[4]刘 然.体质指数与血清C反应蛋白和糖化血红蛋白在妊娠期糖尿病诊断中的意义[J].现代检验医学杂志,2018,33(05):49.[doi:10.3969/j.issn.1671-7414.2018.05.014]
LIU Ran.Diagnostic Significance of BMI,Serum CRP and HbA1c in Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2018,33(06):49.[doi:10.3969/j.issn.1671-7414.2018.05.014]
[5]孙 红,付翠芳,高佳丽,等.妊娠期糖尿病患者血清miR-21,PPARγ和IGF-1R表达水平与凝血功能和妊娠结局的相关性研究[J].现代检验医学杂志,2021,36(05):143.[doi:10.3969/j.issn.1671-7414.2021.05.032]
SUN Hong,FU Cui-fang,GAO Jia-li,et al.Study on the Correlation between Serum miR-21, PPAR γ and IGF-1R Expression Levels in Patients with Gestational Diabetes and BloodCoagulation Function and Pregnancy Outcome[J].Journal of Modern Laboratory Medicine,2021,36(06):143.[doi:10.3969/j.issn.1671-7414.2021.05.032]
[6]许 航,贺 丹,罗 晴.育龄妇女年龄、孕前BMI和孕早期空腹血糖水平分布在妊娠期糖尿病预测中的价值[J].现代检验医学杂志,2021,36(05):169.[doi:10.3969/j.issn.1671-7414.2021.05.037]
XU Hang,HE Dan,LUO Qing.Value of Age, Pre-Pregnancy Body Mass Index and Fasting Blood Glucose inEarly Pregnancy in Predicting Gestational Diabetes Mellitusamong Fertile Women[J].Journal of Modern Laboratory Medicine,2021,36(06):169.[doi:10.3969/j.issn.1671-7414.2021.05.037]
[7]徐 燕,李 晶.孕早期妇女血清人吻素、网膜素-1和Lipasin水平检测对早期预测妊娠期糖尿病发生风险的价值[J].现代检验医学杂志,2022,37(03):119.[doi:10.3969/j.issn.1671-7414.2022.03.025]
XU Yan,LI Jing.Value of Serum Human Kisspeptin, Omentin-1 and Lipasin Levels in Early Pregnant Women for Early Prediction of the Risk of Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2022,37(06):119.[doi:10.3969/j.issn.1671-7414.2022.03.025]
[8]周 青,秦智娟,马宗丽.妊娠期糖尿病患者血清miR-450a-5p 和CREB 表达水平及临床意义[J].现代检验医学杂志,2022,37(04):102.[doi:10.3969/j.issn.1671-7414.2022.04.020]
ZHOU Qing,QIN Zhi-juan,MA Zong-li.Expression Levels and Clinical Significance of Serum miR-450a-5p and CREB in Patients with Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2022,37(06):102.[doi:10.3969/j.issn.1671-7414.2022.04.020]
[9]钟新丽,朱红霞,刘星娅,等.妊娠期糖尿病患者肝脏激酶B1 内含子380C > T 基因多态性与糖脂代谢的关系及评估疾病易感性的价值[J].现代检验医学杂志,2022,37(05):55.[doi:10.3969/j.issn.1671-7414.2022.05.012]
ZHONG Xin-li,ZHU Hong-xia,LIU Xing-ya,et al.Relationship between Liver Kinase B1 (LKB1) Intron 380C>T Gene Polymorphism and Glucose and Lipid Metabolism in Patients with Gestational Diabetes Mellitus (GDM) and Evaluate Value in Assessing Disease Susceptibility[J].Journal of Modern Laboratory Medicine,2022,37(06):55.[doi:10.3969/j.issn.1671-7414.2022.05.012]
[10]张东方,王 茜,李 娟,等.高龄妊娠期糖尿病患者血清miR-351,FGF19 和LP-PLA2 表达水平及其与产后糖代谢异常的相关性研究[J].现代检验医学杂志,2023,38(01):66.[doi:10.3969/j.issn.1671-7414.2023.01.013]
ZHANG Dong-fang,WANG Qian,LI Juan,et al.Serum miR-351, FGF19 and LP-PLA2 Expression Levels in Elderly Patients with Gestational Diabetes Mellitus and Their Correlation with Abnormal Postpartum Glucose Metabolism[J].Journal of Modern Laboratory Medicine,2023,38(06):66.[doi:10.3969/j.issn.1671-7414.2023.01.013]